H.U.B

Brussels, Belgium Founded: 2021 • Age: 5 yrs
A chain of multispecialty hospitals is operated in Brussels.

About H.U.B

H.U.B is a Healthcare company based in Brussels (Belgium) founded in 2021. A chain of multispecialty hospitals is operated in Brussels. Its chief executive, as recorded, is Renaud Witmeur. Its website hubruxelles.be draws about 43 thousand monthly visits. H.U.B offers products and services including Queen Fabiola Children's University Hospital, Erasmus Hospital, and Jules Bordet Institute. Its focus areas include Hospital Chains and Multispecialty Hospital Chains. Its competitors include AZ Sint-Lucas, UZ Leuven and Chirec.

Company details

H.U.B. was established in 2021 as a chain of multispecialty hospitals based in Brussels, Belgium. Healthcare services across various medical specialties are delivered through its facilities. Operations focus on integrated patient care within the hospital network. The organization is led by CEO Renaud Witmeur, with activities centered in the Belgian capital to support regional medical needs.

Key Metrics

Products & Services of H.U.B

H.U.B offers a comprehensive portfolio of products and services, including Queen Fabiola Children's University Hospital, Erasmus Hospital, and Jules Bordet Institute.

Queen Fabiola Children's University Hospital
Pediatric Care

Specialized facility for children's medical treatment and consultations.

Erasmus Hospital
General Hospital

Provides comprehensive medical care for adult patients.

Jules Bordet Institute
Oncological Care

Focuses on cancer diagnosis and treatment services.

Funding Insights of H.U.B

  • Total Rounds 2
  • Last Round Grant β€” $33,673
  • First Round $168,172

    (Oct 2019)

  • Investors Count 1

All 2 funding rounds of H.U.B with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2020$33,673Grant––
Oct 2019$168,172Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in H.U.B

H.U.B has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for H.U.B

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of H.U.B

1 people are tracked at H.U.B (1 in leadership).

NameRoleGroup
Renaud Witmeur
CEOLeadership
Premium access

Complete people profiles for H.U.B

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of H.U.B

3 dated milestones of H.U.B across 2 years, from founding to its latest funding, stage changes and deals.

  1. Funding First funding round of $168K.
  2. Funding Latest funding round, Grant, of $34K.
  3. Founded H.U.B is founded.

Competitors of H.U.B

H.U.B has 3 listed competitors in our database. They include AZ Sint-Lucas, UZ Leuven and Chirec.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
azstlucas.be1998Gentbrugge, Belgium
Multispecialty hospital services are provided by a chain in Belgium.
uzleuven.be2000Leuven, Belgium
Multispecialty hospital services are delivered through a Belgian chain.
chirec.be2000Brussels, Belgium
Chain of multispeciality hospitals
Premium access

Detailed competitors of H.U.B

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of H.U.B

The website of H.U.B (hubruxelles.be) receives about 42.6K visits a month.

  • Monthly visits
    42.6K

    ▲ 44.3% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about H.U.B

H.U.B was founded in 2021.

H.U.B is headquartered in Brussels, Belgium. It is registered at Brussels, Brussels-capital Region, Belgium.

Renaud Witmeur is the CEO of H.U.B, as recorded in our data.

H.U.B. was established in 2021 as a chain of multispecialty hospitals based in Brussels, Belgium. Healthcare services across various medical specialties are delivered through its facilities. Operations focus on integrated patient care within the hospital network. The organization is led by CEO Renaud Witmeur, with activities centered in the Belgian capital to support regional medical needs.

H.U.B's top competitors include UZ Leuven, AZ Sint-Lucas and Chirec.

H.U.B offers Queen Fabiola Children's University Hospital, Erasmus Hospital, and Jules Bordet Institute.

H.U.B has 1 investor. Key investors include European Union.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available